JCM
LKFT

Jacobi Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jacobi Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$24K – 1052
2019
Q1 		$24K Buy
+200
New +$20.2K 0.01% 537

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jacobi Capital Management's LKFT Position: Q2 2019 in Review

Jacobi Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2019, closing a stake of 200 shares — an estimated $24K sold.

Jacobi Capital Management first reported a position in LKFT in Q1 2019 and held it in 1 quarter. The position peaked at $24K in Q1 2019. 102 funds tracked by Wall St. Rank hold LKFT as of Q2 2019.

  • Jacobi Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Jacobi Capital Management sold 200 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2019, an estimated $24K.
  • Jacobi Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2019 and held it in 1 quarter.
  • Jacobi Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $24K in Q1 2019.
  • 102 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2019.

Based on Jacobi Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.